Appl Physiol 1975;39(3):453–456 132 De Buyst J, Rakza T, Pennaforte T, Johansson AB, Storme L Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus J Pediatr 2012;161(3):404–408 133 Green TP, Thompson TR, Johnson DE, Lock JE Diuresis and pulmonary function in premature infants with respiratory distress syndrome J Pediatr 1983;103(4):618–623 134 Green TP, Thompson TR, Johnson DE, Lock JE Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome N Engl J Med 1983;308(13):743– 748 135 Wong R Maintenance diet and the effects of furosemide on hamsters Am J Psychol 1981;94(2):339–354 136 Brion LP, Campbell DE Furosemide in indomethacin-treated infants–systematic review and meta-analysis Pediatric nephrology 1999;13(3):212–218 137 Hammerman C, Glaser J, Kaplan M, et al Indomethacin tocolysis increases postnatal patent ductus arteriosus severity Pediatrics 1998;102(5):E56 138 Ohlsson A, Walia R, Shah S Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants Cochrane Database Syst Rev 2008;(1) [CD003481] 139 Lin YJ, Chen CM, Rehan VK, et al Randomized trial to compare renal function and ductal response between indomethacin and ibuprofen treatment in extremely low birth weight infants Neonatology 2017;111(3):195–202 140 Clyman RI Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies J Pediatr 1996;128(5 Pt 1):601–607 141 Tammela O, Ojala R, Iivainen T, et al Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants J Pediatr 1999;134(5):552–557 142 Schmidt B, Davis P, Moddemann D, et al Longterm effects of indomethacin prophylaxis in extremely-low-birth-weight infants N Engl J Med 2001;344(26):1966–1972 143 Knight DB The treatment of patent ductus arteriosus in preterm infants A review and overview of randomized trials Seminars in neonatology: SN 2001;6(1):63–73 144 Fowlie PW, Davis PG, McGuire W Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants Cochrane Database Syst Rev 2010;(7) [CD000174] 145 Gournay V, Savagner C, Thiriez G, Kuster A, Roze JC Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants Lancet (London, England) 2002;359(9316):1486–1488 146 Kluckow M, Jeffery M, Gill A, Evans N A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus Arch Dis Child Fetal Neonatal Ed 2014;99(2):F99– F104 147 Thomas RL, Parker GC, Van Overmeire B, Aranda JV A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus Eur J Pediatr 2005;164(3):135–140 148 Van Overmeire B, Smets K, Lecoutere D, et al A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus N Engl J Med 2000;343(10):674–681 149 Pezzati M, Vangi V, Biagiotti R, et al Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus J Pediatr 1999;135(6):733– 738 150 Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD Ibuprofen treatment of patent ... Longterm effects of indomethacin prophylaxis in extremely-low-birth-weight infants N Engl J Med 2001 ;344( 26):1966–1972 143 Knight DB The treatment of patent ductus arteriosus in preterm infants A review and